Lannett Stock Forecast, Price & News

+0.22 (+4.66 %)
(As of 06/24/2021 01:38 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume24,186 shs
Average Volume840,365 shs
Market Capitalization$204.74 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive LCI News and Ratings via Email

Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter.

Lannett logo

About Lannett

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

2.29 out of 5 stars

Medical Sector

19th out of 2,105 stocks

Pharmaceutical Preparations Industry

8th out of 832 stocks

Analyst Opinion: 3.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Lannett (NYSE:LCI) Frequently Asked Questions

Is Lannett a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Lannett stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LCI, but not buy additional shares or sell existing shares.
View analyst ratings for Lannett
or view top-rated stocks.

What stocks does MarketBeat like better than Lannett?

Wall Street analysts have given Lannett a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Lannett wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Lannett's next earnings date?

Lannett is scheduled to release its next quarterly earnings announcement on Wednesday, August 25th 2021.
View our earnings forecast for Lannett

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) announced its quarterly earnings results on Wednesday, May, 5th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.05) by $0.07. The company had revenue of $112.30 million for the quarter, compared to analysts' expectations of $116.11 million. Lannett had a positive trailing twelve-month return on equity of 9.28% and a negative net margin of 38.24%. The company's revenue for the quarter was down 22.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.27 EPS.
View Lannett's earnings history

How has Lannett's stock price been impacted by Coronavirus (COVID-19)?

Lannett's stock was trading at $7.74 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, LCI shares have decreased by 36.2% and is now trading at $4.94.
View which stocks have been most impacted by COVID-19

What guidance has Lannett issued on next quarter's earnings?

Lannett issued an update on its FY 2021 earnings guidance on Wednesday, May, 26th. The company provided earnings per share (EPS) guidance of - for the period. The company issued revenue guidance of $480 million-$500 million, compared to the consensus revenue estimate of $492.84 million.

What price target have analysts set for LCI?

3 Wall Street analysts have issued 1-year price objectives for Lannett's shares. Their forecasts range from $6.00 to $7.00. On average, they expect Lannett's share price to reach $6.50 in the next twelve months. This suggests a possible upside of 31.6% from the stock's current price.
View analysts' price targets for Lannett
or view top-rated stocks among Wall Street analysts.

Who are Lannett's key executives?

Lannett's management team includes the following people:
  • Mr. Timothy C. Crew, CEO & Director (Age 60, Pay $2.13M)
  • Mr. John Kozlowski, VP of Fin., CFO & Principal Accounting Officer (Age 49, Pay $926.75k)
  • Mr. John M. Abt, VP and Chief Quality & Operations Officer (Age 56, Pay $898.59k)
  • Mr. Samuel H. Israel, Gen. Counsel & Chief Legal Officer (Age 59, Pay $1.06M)
  • Ms. Maureen M. Cavanaugh, Sr. VP & Chief Commercial Operations Officer (Age 62, Pay $1.1M)
  • Mr. Robert Ehlinger, VP & Chief Information Officer (Age 64)
  • Ms. Kristie Stephens, Chief Compliance Officer & VP of Regulatory Affairs
  • Mr. Grant Brock, VP of Operations

What is Timothy Crew's approval rating as Lannett's CEO?

9 employees have rated Lannett CEO Timothy Crew on Glassdoor.com. Timothy Crew has an approval rating of 28% among Lannett's employees. This puts Timothy Crew in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Lannett's key competitors?

What other stocks do shareholders of Lannett own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include (CELG), Akorn (AKRX), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA).

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

Who are Lannett's major shareholders?

Lannett's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (13.29%), JPMorgan Chase & Co. (8.30%), D. E. Shaw & Co. Inc. (4.66%), Renaissance Technologies LLC (4.46%), LSV Asset Management (4.31%) and Dimensional Fund Advisors LP (2.62%). Company insiders that own Lannett stock include Albert Paonessa III, David A Drabik, Jeffrey Farber, Patrick G Lepore and Timothy C Crew.
View institutional ownership trends for Lannett

Which institutional investors are selling Lannett stock?

LCI stock was sold by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, JPMorgan Chase & Co., Goldman Sachs Group Inc., Northern Trust Corp, Citigroup Inc., LSV Asset Management, Russell Investments Group Ltd., and Renaissance Technologies LLC.
View insider buying and selling activity for Lannett
or view top insider-selling stocks.

Which institutional investors are buying Lannett stock?

LCI stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Factorial Partners LLC, Dimensional Fund Advisors LP, Squarepoint Ops LLC, Exchange Traded Concepts LLC, 6 Meridian, and D. E. Shaw & Co. Inc.. Company insiders that have bought Lannett stock in the last two years include Jeffrey Farber, Patrick G Lepore, and Timothy C Crew.
View insider buying and selling activity for Lannett
or or view top insider-buying stocks.

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $4.94.

How much money does Lannett make?

Lannett has a market capitalization of $204.74 million and generates $545.74 million in revenue each year. The company earns $-33,370,000.00 in net income (profit) each year or $1.07 on an earnings per share basis.

How many employees does Lannett have?

Lannett employs 954 workers across the globe.

What is Lannett's official website?

The official website for Lannett is www.lannett.com.

Where are Lannett's headquarters?

Lannett is headquartered at 9000 STATE ROAD, PHILADELPHIA PA, 19136.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at 215-333-9000.

This page was last updated on 6/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.